Tobacco Cessation: Curb the Deadliest Epidemic Keith Bradley, MD Director, Research Associates Program at St. Vincent’s National Alliance of Research Associates.

Slides:



Advertisements
Similar presentations
Bronx BREATHES: Resources and Technical Assistance for Improved Tobacco Treatment Barbara Hart, MPA David Lounsbury, PhD Claudia Lechuga, MS Hal Strelnick,
Advertisements

Nicotine Addiction Pharmacy Practice II Winter 2005.
STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
I do not have any relevant financial relationships to disclose.
Intervention and Promotion Makes a Difference Tobacco cessation intervention by healthcare providers improves quit rates. Brief counseling is all that.
SETTING OUR COMPASS QuitlineNC: Partnering to Improve Tobacco Cessation in North Carolina.
Tobacco & Cancer. Tobacco Use And Cancer Tobacco use, the most preventable cause of death in our society, accounts for at least 30% of all cancer deaths.
Tobacco Dependence Nancy A. Rigotti, M.D. Director, Tobacco Research & Treatment Center Massachusetts General Hospital Associate Professor of Medicine.
Chapter 8—Caffeine & Nicotine Robert M. Julien Presentation By: Tamyra Frazier & Sarah Massamore.
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
Treatment of Tobacco Dependence in 2012 J. Taylor Hays, MD Professor of Medicine Associate Director Nicotine Dependence Center Mayo Clinic Rochester, MN.
1 The Impact of Smoking in Los Angeles County March 25, 2010 Jonathan Fielding, M.D., M.P.H., M.B.A Director of Public Health and Health Officer L.A. County.
Systems Strategies to Address Tobacco Use: Utilizing EHRs to Improve Patient Care Ryan Reikowsky, MA, MPH Manager, Community Development Arizona Smokers’
Vinni Swad Zander Thompson
Presinted by :Shahd Amer.  Tobacco ads may make you feel like everyone is doing it but they are not.  Only about 28% of high school students smoke.
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Smoking Cessation Pathway Reducing the infant mortality rate in Cincinnati and Hamilton County.
Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.
Basics: 2As & R Clinical Intervention Artwork by Nancy Z. © 2010 American Aca0emy of Pediatrics (AAP) Children's Art Contest. Support for the 2010 AAP.
Tobacco Cessation and Private Insurance under ACA: New Opportunities for Public Health September 25, 2014.
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
Evidence-based practice: Smoking Cessation Program SMOKING CESSATION Utilizing Evidence Based Guidelines To Establish An Appropriate Standard of Care For.
Establish and Sustain Tobacco Cessation Programs.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.
The Ohio Partners for Smoke-Free Families 5A’s
Quitting Smoking How to stop smoking … for good!.
Smoking Cessation for Pregnancy and Beyond: Virtual Clinic Companion Slides Catherine A. Powers, EdD, LSW PACE – Tobacco Prevention and Cessation Education.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
2010 PHS Clinical Practice Guidelines: Smoking Cessation CDR Sherri Yoder PharmD, BCPS, CER Program Principal Consultant Indian Health Service USPHS COA.
A presentation for [INSERT EVENT/ORGANIZATION] [INSERT DATE] [INSERT PRESENTER NAMES/ORGS]
Lung cancer, like all cancers, happens with abnormal cell function. Lung cancer is a very life threatening cancer, as it tends to spread early and is.
CDC Best Practices - States Roundtable Treatment of Tobacco Use and Dependence CDC Best Practices - States Roundtable Treatment of Tobacco Use and Dependence.
1 Progress in the development, monitoring, and implementation of tobacco dependence treatment around the world 13 March, 2013 Boston, MA.
Smoking Cessation: the pharmacotherapeutic and non-pharmacotherapeutic approaches to addictive behavior Andrea C. McKean February 22, 2007.
Who Smokes and Why. Prevalence Current estimates for US: 25% of adults smoke. High was 41% in Current estimates for US: 25% of adults smoke. High.
Rene Maximiliano Gomez, MD Head, Allergy & Asthma Unit Hospital San Bernardo, Salta - Argentina.
Quit For Life® Program Presented by Helen Farid 1.
Le rôle de la réduction de dommages dans la lutte antitabac The role of harm reduction in tobacco control Lars M. Ramström Institute for Tobacco Studies.
1 David B. Abrams, Ph.D National Conference on Tobacco or Health Dec Boston The Centers for Behavioral & Preventive Medicine Brown Medical School,
 Small cell lung cancer is named based on the size of the cells that cause the cancer. It accounts for about 20% of lung cancer cases.  It also referred.
Smoking Cessation: Counseling and Resources Catherine A. Powers, EdD, LSW Boston University School of Medicine.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Linking Together to.
Risk Factors for Smoking in the EMR Region Kawkab Shishani, BSN, PhD The Hashemite University Risk Factors for Smoking in the EMR Region Kawkab Shishani,
TOBACCO USE & OLDER SMOKERS. OLDER SMOKERS In 2004, 3.7 million people aged 65 and older were smokers and 16% of all people aged 50 and older smoked;
Laws/Policies ABSTRACT Problem: A challenge for tobacco control practitioners is getting smokers to quit using cessation methods. To increase the proportion.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
Tobacco Cessation Strategies and Resources: Epidemiology, Evidence and Availability May 29, 2013 The National Tobacco-Free College Campus Initiative: Building.
Module 35 Psychological Aspects of Illness Chapter 110 Essentials of Understanding Psychology- Sixth Edition PSY110 Psychology © Richard Goldman June.
July 2006 Treating Tobacco Use and Dependence. Learning Objectives At the end of this session you should understand: The impact of tobacco dependence.
 1,400 Montanans die a year from a tobacco related disease  In 2009, 16% or approx 118,00 Montana adults were current smokers  In 2009, approx 50,000.
Living Tobacco-Free It really is possible!. Agenda Statistics and mortality risks Health risks Benefits of quitting Ways to quit.
Factors associated with health care providers’ practice of smoking cessation interventions in public health facilities in Kiambu County, Kenya Dr Judy.
Policies for helping smokers who cannot quit: a prerequisite for maximum prevention of tobacco induced diseases Lars M. Ramström Institute for Tobacco.
 2009 Johns Hopkins Bloomberg School of Public Health; American Academy of Pediatrics Julius B. Richmond Center of Excellence Dana Best, MD, MPH, FAAP.
Clinical Initiatives Supporting the Treatment of Tobacco Use Dependence Jim Bluhm, MPH Project Manager Blue Cross and Blue Shield of Minnesota Center for.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
A Resource for Tobacco Dependence Treatment Michigan Tobacco Quitline Washtenaw County Public Health May 2016.
6 myths and facts about tobacco use disorder in people with mental health and substance use disorders Associate Professor.
screening, brief intervention, and referral to treatment
Assistant professor Family Medicine - Suez Canal University
Tobacco Cessation Guidelines for COPD
The Burden of Tobacco Use
ABCs of Behavioral Support
RESTRICTING THE USE OF TOBACCO
Tobacco Cessation for Primary Care Providers
Presentation transcript:

Tobacco Cessation: Curb the Deadliest Epidemic Keith Bradley, MD Director, Research Associates Program at St. Vincent’s National Alliance of Research Associates Programs (NARAP)

Nicotine-Related Pathology coronary artery peripheral vascular disease hypertension peptic ulcer disease fetal mortality and morbidity cancer

Lung Cancer All lung cancers begin as small focus of uncontrolled cell division → thickening/piling up of bronchial mucosa.

Lung Cancer Small cell Adenocarcinoma Squamous carcinoma Large cell carcinoma

Small Cell Carcinoma

20% of all lung cancers

Small Cell Carcinoma 20% of all lung cancers highly aggressive, metastasizing early.

Small Cell Carcinoma 20% of all lung cancers highly aggressive, metastasizing early. only 1% of cases occur in non-smokers

Small Cell Carcinoma 20% of all lung cancers highly aggressive, metastasizing early. only 1% of cases occur in non-smokers incurable by surgery

Small Cell Carcinoma 90% of small cell carcinomas begin in central airways

Small Cell Carcinoma 90% of small cell carcinomas begin in central airways –consistent with smoking association

Small Cell Carcinoma 90% of small cell carcinomas begin in central airways –consistent with smoking association Small cell staged as limited or extensive (spread outside chest)

Small Cell Carcinoma 90% of small cell carcinomas begin in central airways –consistent with smoking association Small cell staged as limited or extensive (spread outside chest) –70% are extensive at diagnosis

Adenocarcinoma

About 40% of lung cancer cases in the US

Adenocarcinoma About 40% of lung cancer cases in the US The most common lung cancer among women

Adenocarcinoma About 40% of lung cancer cases in the US The most common lung cancer among women –number of new cases is increasing

Adenocarcinoma About 40% of lung cancer cases in the US The most common lung cancer among women –number of new cases is increasing Usually starts near the outer edges of the lungs

Adenocarcinoma About 40% of lung cancer cases in the US The most common lung cancer among women, –number of new cases is increasing Usually starts near the outer edges of the lungs Often metastasized at diagnosis

Squamous Carcinoma

25-30% of lung cancer cases in the US

Squamous Carcinoma 25-30% of lung cancer cases in the US Occurs most frequently in men and the elderly

Squamous Carcinoma 25-30% of lung cancer cases in the US Occurs most frequently in men and the elderly Usually starts in one of the larger breathing tubes

Squamous Carcinoma 25-30% of lung cancer cases in the US Occurs most frequently in men and the elderly Usually starts in one of the larger breathing tubes Tends to grow relatively slowly

Squamous Carcinoma 25-30% of lung cancer cases in the US Occurs most frequently in men and the elderly Usually starts in one of the larger breathing tubes Tends to grow relatively slowly Tends to remain localized in the chest longer than other types of lung cancer

Squamous Carcinoma 25-30% of lung cancer cases in the US Occurs most frequently in men and the elderly Usually starts in one of the larger breathing tubes Tends to grow relatively slowly Tends to remain localized in the chest longer than other types of lung cancer Does not metastasize early

Large Cell Carcinoma

“Other” –tend to have larger cells than other types of lung cancer

Large Cell Carcinoma “Other” –tend to have larger cells than other types of lung cancer Incidence appears to be decreasing –may be due to improvements in determining the types of lung cancer

Large Cell Carcinoma “Other” –tend to have larger cells than other types of lung cancer Incidence appears to be decreasing –may be due to improvements in determining the types of lung cancer 10-15% of lung cancer cases in the US

Large Cell Carcinoma “Other” –tend to have larger cells than other types of lung cancer Incidence appears to be decreasing –may be due to improvements in determining the types of lung cancer % of lung cancer cases in the US Usually starts in the smaller breathing tubes

Large Cell Carcinoma “Other” –tend to have larger cells than other types of lung cancer Incidence appears to be decreasing –may be due to improvements in determining the types of lung cancer 10-15% of lung cancer cases in the US Usually starts in the smaller breathing tubes May occur in any part of the lung

Large Cell Carcinoma “Other” –tend to have larger cells than other types of lung cancer Incidence appears to be decreasing –may be due to improvements in determining the types of lung cancer % of lung cancer cases in the US Usually starts in the smaller breathing tubes May occur in any part of the lung Tumors are usually large at diagnosis

Large Cell Carcinoma “Other” –tend to have larger cells than other types of lung cancer Incidence appears to be decreasing –may be due to improvements in determining the types of lung cancer % of lung cancer cases in the US Usually starts in the smaller breathing tubes May occur in any part of the lung Tumors are usually large at diagnosis Tends to invade the mediastinum (chest area behind the breastbone)

Large Cell Carcinoma “Other” –tend to have larger cells than other types of lung cancer Incidence appears to be decreasing –may be due to improvements in determining the types of lung cancer % of lung cancer cases in the US Usually starts in the smaller breathing tubes May occur in any part of the lung Tumors are usually large at diagnosis Tends to invade the mediastinum (chest area behind the breastbone) Metastasizes to the central nervous system

Nicotine Addiction

Psychoactive

Nicotine Addiction Psychoactive –dose-related changes in mood and feeling

Nicotine Addiction Psychoactive –dose-related changes in mood and feeling –transient

Nicotine Addiction Psychoactive –dose-related changes in mood and feeling –transient Euphoriant

Nicotine Addiction Psychoactive –dose-related changes in mood and feeling –transient Euphoriant –dose-related increases in scores on standard measures of euphoria.

Nicotine Addiction Psychoactive –dose-related changes in mood and feeling –transient Euphoriant –dose-related increases in scores on standard measures of euphoria. Reinforcer

Nicotine Addiction Psychoactive –dose-related changes in mood and feeling –transient Euphoriant –dose-related increases in scores on standard measures of euphoria. Reinforcer Neuroadaptation

Nicotine Addiction Psychoactive –dose-related changes in mood and feeling –transient Euphoriant –dose-related increases in scores on standard measures of euphoria. Reinforcer Neuroadaptation –leading to tolerance and physiologic dependence.

Nicotine Addiction nicotine from the use of tobacco has ≈ physical addiction potential as morphine

Nicotine Addiction nicotine from the use of tobacco has ≈ physical addiction potential as morphine ≈ psychic dependence as cocaine

Smokeless Tobacco pharmacokietics of nicotine (i.e., absorption, distribution, and elimination) from smoking and from smokeless tobacco → magnitude of nicotine exposure similar

Tobacco Cessation

Treating Tobacco Use and Dependence. U.S. Public Health Service. kesum.htm kesum.htm Guideline, Treating Tobacco Use and Dependence –based on the literature review and expert panel opinion

Which Smokers Offered Cessation ? Because effective tobacco dependence treatments are available, every patient who uses tobacco should be offered at least one of these treatments: –Patients willing to try to quit tobacco use should be provided treatments identified as effective in this guideline. –Patients unwilling to try to quit tobacco use should be provided a brief intervention designed to increase their motivation to quit.

Which Smokers Offered Cessation ? “It is essential that clinicians and health care delivery systems … institutionalize the consistent identification, documentation, and treatment of every tobacco user seen in a health care setting.”

Brief Tobacco Dependence Tx

should be: –effective

Brief Tobacco Dependence Tx should be: –effective –offered to every patient who uses tobacco

Brief Tobacco Dependence Tx should be: –effective –offered to every patient who uses tobacco Quitlines

Brief Tobacco Dependence Tx should be: –effective –offered to every patient who uses tobacco Quitlines: –mandated by tobacco company settlements

Brief Tobacco Dependence Tx should be: –effective –offered to every patient who uses tobacco Quitlines: –mandated by tobacco company settlements –about 30-40% effective

Tx Dose-Response Relationship

strong relationship between intensity of tobacco dependence counseling and its effectiveness

Tx Dose-Response Relationship strong relationship between intensity of tobacco dependence counseling and its effectiveness person-to-person treatments (individual, group, or telephone counseling)

Tx Dose-Response Relationship strong relationship between intensity of tobacco dependence counseling and its effectiveness person-to-person treatments (individual, group, or telephone counseling): –consistently effective

Tx Dose-Response Relationship strong relationship between intensity of tobacco dependence counseling and its effectiveness person-to-person treatments (individual, group, or telephone counseling): –consistently effective – effectiveness increases with treatment intensity (e.g., minutes of contact)

Types of Counseling and Behavioral Tx

1.Provision of practical counseling (problem solving/skills training)

Types of Counseling and Behavioral Tx 1.Provision of practical counseling (problem solving/skills training) 2.Provision of social support as part of tx (intra-treatment social support)

Types of Counseling and Behavioral Tx 1.Provision of practical counseling (problem solving/skills training) 2.Provision of social support as part of tx (intra-treatment social support) 3.Help in securing social support outside of tx (extra-treatment social support)

Pharmacotherapies

Reliably increase long-term smoking abstinence

Pharmacotherapies Reliably increase long-term smoking abstinence Nicotine –gum –inhaler –nasal spray –patch

Pharmacotherapies Reliably increase long-term smoking abstinence Nicotine –gum –inhaler –nasal spray –patch “ Over-the-counter nicotine patches are effective relative to placebo, and their use should be encouraged.”

Pharmacotherapies Reliably increase long-term smoking abstinence Nicotine –gum –inhaler –nasal spray –patch “ Over-the-counter nicotine patches are effective relative to placebo, and their use should be encouraged.” Bupropion (Wellbutrin) SR Other anti-depressants

Effective Pharmacotherapies Except in the presence of contraindications, these should be used with all patients attempting to quit smoking.

$ ?

Insurers should include as a reimbursed benefit:

$ ? Insurers should include as a reimbursed benefit: counseling and pharmacotherapeutic treatments identified as effective in this guideline.

$ ? Insurers should include as a reimbursed benefit: counseling and pharmacotherapeutic treatments identified as effective in this guideline. clinicians for providing tobacco dependence treatment just as they are reimbursed for treating other chronic conditions.

Clinicians and Tobacco Cessation About 20 years ago, data indicated that clinicians too frequently failed to intervene with their patients who smoke.

Clinicians and Tobacco Cessation About 20 years ago, data indicated that clinicians too frequently failed to intervene with their patients who smoke. Recent data confirm this has not changed markedly over the past two decades.

Clinicians and Tobacco Cessation One recent study reported: only 15 percent of smokers who saw a physician in the past year were offered assistance with quitting

Clinicians and Tobacco Cessation One recent study reported: only 15 percent of smokers who saw a physician in the past year were offered assistance with quitting only 3 percent were given a follow-up appointment to address this topic.

Bottom Line These evidence-based guidelines reveal:

Bottom Line These evidence-based guidelines reveal: 1.multiple efficacious tobacco cessation tx exist

Bottom Line These evidence-based guidelines reveal: 1.multiple efficacious tobacco cessation tx exist 2.these tx can double or triple the likelihood of long- term cessation

Bottom Line These evidence-based guidelines reveal: 1.multiple efficacious tobacco cessation tx exist 2.these tx can double or triple the likelihood of long- term cessation 3.many cessation tx are appropriate for the primary care setting

Bottom Line These evidence-based guidelines reveal: 1.multiple efficacious tobacco cessation tx exist 2.these tx can double or triple the likelihood of long- term cessation 3.many cessation tx are appropriate for the primary care setting 4.cessation tx are more cost-effective than many other reimbursed clinical interventions

Bottom Line These evidence-based guidelines reveal: 1.multiple efficacious tobacco cessation tx exist 2.these tx can double or triple the likelihood of long- term cessation 3.many cessation tx are appropriate for the primary care setting 4.cessation tx are more cost-effective than many other reimbursed clinical interventions 5.utilization and impact of cessation treatments can be increased by supportive health system policies (e.g., coverage through insurance)

?